Unigene Laboratories Inc. (UGNE) News

News for Unigene Laboratories Inc.  (UGNE) 
Sector News | Topic News
$ 0.60   0.05 (+9.09%) Volume: 71.3 k 2:38 PM EST Feb 10, 2012
View News From:  
Wed, Feb 08, 2012
9:51 AM Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit Continues to Grow in 2012 - PR Newswire
Tue, Feb 07, 2012
8:33 AM Unigene to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 - PR Newswire
Wed, Feb 01, 2012
9:51 AM Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award - PR Newswire
Wed, Jan 11, 2012
8:31 AM Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity - PR Newswire
Mon, Jan 09, 2012
8:31 AM Unigene Provides 2012 Business Outlook - PR Newswire
Wed, Jan 04, 2012
8:01 AM Unigene to Present at Biotech Showcase(tm) 2012 in San Francisco on January 9 - PR Newswire
Mon, Dec 19, 2011
8:31 AM Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012 - PR Newswire
Wed, Dec 07, 2011
8:02 AM Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011 - PR Newswire
Mon, Dec 05, 2011
8:02 AM Unigene Regains Exclusive Worldwide Rights of Oral PTH from GSK - PR Newswire
Wed, Nov 30, 2011
8:02 AM Unigene's Proprietary Peptelligence(tm) Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist - PR Newswire
Wed, Nov 16, 2011
7:03 AM Unigene Strengthens Board with the Appointment of Walgreen's Executive, Thomas J. Sabatino, Jr. - PR Newswire
Mon, Nov 14, 2011
6:12 AM Unigene Announces Novartis' Disclosure of First Interpretable Results from Phase 3 Trial of Calcitonin (SMC021) in the Treatment of Post-menopausal Osteoporosis - Business Wire
Thu, Nov 10, 2011
8:10 AM Unigene to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011 - PR Newswire
Wed, Nov 09, 2011
8:10 AM Unigene Announces Positive Top-Line Results of Phase 2 Oral PTH Study for the Treatment of Osteoporosis in Postmenopausal Women - PR Newswire
8:01 AM Unigene Reports Third Quarter 2011 Financial Results - PR Newswire
Mon, Nov 07, 2011
8:02 AM Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011 - PR Newswire
Fri, Dec 11, 2009
4:57 PM AllPennyStocks.com Announces December 14th to December 18th U.S. Penny Stocks 2 Watch (CHCG.OB, UGNE.OB) - Accesswire
 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.